(Q21090878)
Statements
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard (English)
0 references
1 reference
Christine Schmucker
Christine
Schmucker
1 reference
Monika Lelgemann
Monika
Lelgemann
1 reference
Christoph Ehlken
Christoph
Ehlken
1 reference
1 reference
Hansjuergen T
Agostini
Hansjuergen T Agostini
1 reference
Gerta Ruecker
1 reference
3 August 2012
4 references
25 June 2019
27 September 2019
27 November 2019
13 December 2019
4 references
25 June 2019
27 September 2019
27 November 2019
13 December 2019
7
0 references
8
0 references
e42701
0 references
4 references
25 June 2019
27 September 2019
27 November 2019
13 December 2019
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference